Weight loss plateaus, return of appetite, increased blood sugar readings, and decreased metabolic effects can all signal that your medication has lost potency
Both reduce pain, but they work through different mechanisms at different potencies
What Clinical Research Shows Clinical trials on GLP-1 medications have shown significant average weight loss when patients reached and maintained target doses while also following reduced-calorie diets and increasing physical activity
People with type 2 diabetes using tirzepatide alongside other diabetes medications face hypoglycemia risks that those using it for weight loss alone do not
By mimicking the effects of these natural hormones, Tirzepatide stimulates insulin production, reduces glucagon secretion, and helps control appetite
Diarrhea Diarrhea affects about 29.7% of semaglutide 2.4 mg users in the STEP trials versus 15.9% on placebo